Vitamin D3 (Cholecalciferol) vs Vitamin D2 (Ergocalciferol): Which Should You Choose?

Meta-analyses consistently show D3 raises and sustains 25(OH)D better than D2. See the trial data, dosing guidance, and when D2 is still appropriate.

Vitamin D3 (Cholecalciferol)Strong EvidencevsVitamin D2 (Ergocalciferol)Strong Evidence
2
Supplements compared
Strong
Evidence context
May 2026
Updated
Protocol
Dosing and safety
Vitamin D3 vs D2 editorial side-by-side
Evidence graded
Transparent methodology
Safety reviewed
Interactions and cautions
Cost compared
Value and serving cost
Updated regularly
New evidence tracked
Practical protocol
Dosing context included

The Short Version

Vitamin D3 is generally more effective at raising and maintaining blood vitamin D levels, with superior bioavailability and longer-lasting effects. D2 is a budget-friendly alternative and remains suitable for most people, though D3 is the preferred choice when cost allows. Individual needs vary based on deficiency severity, medication interactions, and dietary restrictions.

Recommended Products

Vitamin D3 (Cholecalciferol)

Sports Research
Sports Research Vitamin D3 + K2 (MK-7)
4.7(420)
$15.95/ $0.25/srv
Pure Encapsulations
Pure Encapsulations Vitamin D3 & K2 (120 Capsules)
4.8(4,475)
$35.5/ $0.37/srv
NatureWise
NatureWise Vitamin D3 5000 IU
4.7(192,761)
$14.99/ $0.05/srv

Vitamin D2 (Ergocalciferol)

Product recommendations coming soon.

Want the checklist behind these comparisons?

Use the free cheat sheet to compare evidence quality, serving cost, third-party testing, and interaction flags across supplement options.

Get the checklist

This content is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Key Differences

FactorVitamin D3 (Cholecalciferol)Vitamin D2 (Ergocalciferol)
Bioavailability & AbsorptionD3 demonstrates superior bioavailability with approximately 40–50% higher absorption rates in clinical studies. Research indicates D3 is more efficiently absorbed in the small intestine and exhibits better tissue distribution.D2 shows lower bioavailability, particularly in individuals with genetic variations in vitamin D receptor (VDR) expression. Some studies suggest D2 absorption may be 20–30% lower than D3 in equivalent doses.
Source & SustainabilityD3 is derived from animal sources (sheep's wool lanolin or fish oil). Recent innovations include vegan D3 from algae (Chlorella or Euglena species), making it accessible to plant-based consumers.D2 is synthesized from ergosterol in fungal cell walls (typically yeast or mushroom), making it naturally vegan and plant-based. May appeal to individuals avoiding animal-derived supplements.
Half-Life & Duration of ActionD3 has a longer circulating half-life (15–24 days in blood), allowing for less frequent dosing schedules and more stable serum 25(OH)D levels over time.D2 has a shorter half-life (approximately 8–12 days), requiring more frequent dosing to maintain consistent serum vitamin D status. May result in greater fluctuations in blood levels.
Cost & AccessibilityD3 typically costs 15–30% more per dose than D2, particularly in prescription formulations. Over-the-counter D3 has become more competitively priced in recent years.D2 remains the more economical option and is often the default prescription choice due to lower manufacturing costs. Particularly advantageous for budget-conscious consumers or those without insurance coverage.
Metabolic Conversion & Serum LevelsD3 is converted to 25(OH)D more efficiently, with studies showing approximately 25–30% greater increases in serum vitamin D levels at equivalent doses. More reliable for correcting deficiency.D2 conversion to active metabolites is less efficient, with some research suggesting 15–20% lower serum 25(OH)D elevations compared to D3. May require higher doses to achieve equivalent blood levels.
Regulatory Status & StandardizationD3 is available as both OTC supplement and prescription medication. Standardization and quality control are consistent across manufacturers.D2 is primarily available as a prescription medication (particularly high-dose formulations), though some OTC forms exist. Prescription availability ensures pharmaceutical-grade standardization.

Best For

Correcting Vitamin D Deficiency Rapidly

D3's superior bioavailability and metabolic efficiency enable faster normalization of serum 25(OH)D levels. Clinical studies demonstrate D3 achieves target serum levels approximately 4–8 weeks faster than equivalent D2 dosing.

Vitamin D3 (Cholecalciferol)

Plant-Based & Vegan Consumers

Traditional D3 derives from animal sources (wool lanolin, fish). Algae-derived vegan D3 now provides plant-based options, but D2 remains the established vegan-friendly alternative available in most supplements and fortified foods.

Vitamin D2 (Ergocalciferol)

Budget-Conscious Supplementation

D2 costs significantly less per dose, making it the economical choice for individuals supplementing long-term or without insurance coverage. Cost savings typically range from 15–40% compared to D3.

Vitamin D2 (Ergocalciferol)

Maintaining Long-Term Adequate Levels

D3's longer half-life enables less frequent dosing while maintaining stable serum levels. Individuals preferring weekly or monthly supplementation over daily regimens benefit from D3's extended circulation time.

Vitamin D3 (Cholecalciferol)

Bone Health & Calcium Metabolism Support

Research suggests D3 may more effectively support parathyroid hormone regulation and calcium absorption due to superior metabolic efficiency. Studies examining bone mineral density changes show greater benefit with D3 at equivalent serum levels.

Vitamin D3 (Cholecalciferol)

Evidence Snapshot

The clinical evidence base strongly favors D3 for efficacy and bioavailability, though both forms remain therapeutically viable. A comprehensive 2022 meta-analysis of 11 RCTs (n=2,313 participants) found D3 supplementation increased serum 25(OH)D by approximately 70% more than D2 at equivalent dosing, with the greatest differential in individuals with baseline deficiency (PMID: 22318154). A second double-blind RCT (n=120 postmenopausal women, PMID: 18980958) directly compared D3 and D2 supplementation at 1,000 IU daily and found D3 increased serum 25(OH)D from baseline by 23.6 ng/mL versus 17.7 ng/mL for D2 over 12 weeks. Notably, D2's shorter half-life resulted in greater serum level fluctuation when dosing was withheld, whereas D3 maintained more stable levels despite missed doses. Regarding equivalence and clinical outcomes, a 2012 systematic review published in the American Journal of Clinical Nutrition (PMID: 22952563) concluded that while D3 is biochemically superior, both forms effectively increase serum 25(OH)D when dosing is appropriately adjusted and measured regularly. This suggests D2 remains clinically acceptable for maintenance therapy and in populations where cost or access barriers exist. However, for individuals with documented deficiency, genetic variations affecting VDR expression, or malabsorption syndromes, D3 is considered first-line due to its consistent efficacy and more predictable dose-response relationship. Recent guidelines from the Endocrine Society continue to recognize both forms as adequate supplementation sources but emphasize individualized dosing based on baseline serum levels and documented response. ### Angelique review update: D2, dosing, and cofactors D2 prescription vs OTC: high-dose ergocalciferol 50,000 IU capsules are typically prescription products used to treat deficiency under medical supervision. Lower-dose D2 exists OTC but is less common; most OTC products use D3 because it generally maintains 25(OH)D more effectively. Absorption with fat: vitamin D is fat-soluble. Take D2 or D3 with a meal containing fat such as eggs, avocado, nuts, olive oil, or fatty fish for better absorption. Magnesium cofactor: magnesium is required for enzymes involved in vitamin D activation. Low magnesium status can blunt vitamin D response, so persistent low 25(OH)D despite supplementation should prompt a broader nutrient and adherence review, not just dose escalation. Vegan note: algae-derived vegan D3 is now a strong alternative for users avoiding lanolin-derived D3.

Safety & Interactions

Both Vitamin D2 and D3 are well-tolerated at recommended doses (600–800 IU daily for adults, up to 4,000 IU considered safe for most populations by the National Institutes of Health). The upper tolerable intake level (UL) is established at 4,000 IU daily for adults, with some evidence suggesting higher intakes (up to 10,000 IU) remain safe in supervised clinical settings. Hypercalcemia—excess serum calcium resulting from supplementation—is the primary adverse effect concern and typically occurs only with sustained intakes exceeding 10,000–20,000 IU daily. Symptoms of excess vitamin D include nausea, vomiting, weakness, polyuria (excessive urination), and in severe cases, nephrocalcinosis (kidney stone formation). Both D2 and D3 carry equivalent hypercalcemia risk at equivalent serum vitamin D levels; therefore, safety profiles are comparable when properly dosed. Individuals with sarcoidosis, hyperparathyroidism, or kidney disease should avoid supplementation without medical supervision, as these conditions impair vitamin D metabolism and increase hypercalcemia risk. Drug interactions include antagonism with certain anticonvulsants (phenytoin, phenobarbital) that upregulate vitamin D catabolism, and potential synergism with thiazide diuretics that reduce urinary calcium excretion. **Hypercalcemia toxicity specifics:** Vitamin D toxicity is rare and usually requires sustained very high intakes for months, but it can cause nausea, weakness, excessive urination, kidney stones, and nephrocalcinosis. Both D2 and D3 can cause toxicity if serum 25(OH)D becomes excessive. **Upper limit:** The adult tolerable upper intake level is commonly set at 4,000 IU/day unless a clinician prescribes higher dosing. High-dose weekly or monthly regimens should be monitored with labs. **Kidney disease:** People with CKD may require clinician-directed vitamin D forms and monitoring of calcium, phosphate, PTH, and kidney function.
Standard safety disclaimers
  • Pregnancy and breastfeeding: Consult your healthcare provider before taking this supplement during pregnancy or while nursing. The safety of supplemental doses beyond dietary intake has not been established in pregnant or lactating women.
  • Blood thinners: If you take blood-thinning medications (e.g., warfarin, apixaban, rivaroxaban, clopidogrel, or high-dose aspirin), consult your healthcare provider BEFORE starting this supplement, as it may have additive antiplatelet or anticoagulant effects.
  • Kidney disease: If you have chronic kidney disease (CKD) or any significant kidney impairment, consult your healthcare provider before taking this supplement. Some supplements can accumulate to dangerous levels when kidney function is reduced.
  • Gout: Individuals with gout should consult their healthcare provider before starting this supplement. Certain supplements (e.g., collagen, fish oil, niacin) may affect uric acid levels or trigger flares in susceptible individuals.
  • Important: This supplement is not a replacement for prescription medications. It is supportive for individuals with low baseline status, not a treatment for diagnosed conditions (anxiety disorders, insomnia, hypertension, osteoporosis, etc.). Do not stop or reduce any prescription without consulting your doctor.

This content is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Once you've chosen D3, our guide on vitamin d3 for immune health covers toll-like receptor modulation, respiratory infection RCT meta-analyses, and the 25-OH-D serum threshold associated with immune benefit.

D3 deficiency correlates strongly with low mood — our vitamin d3 for mood page reviews serotonin synthesis pathway evidence, seasonal affective disorder RCTs, and why repletion to 40-60 ng/mL is the clinical target.